Azilsartan Methyl Ester

CAS No. 147403-52-9

Azilsartan Methyl Ester( —— )

Catalog No. M35894 CAS No. 147403-52-9

Azilsartan Methyl Ester is an angiotensin II receptor antagonist. Azilsartan Methyl Ester inhibits specific binding of [125I]AII (0.2 nM) to bovine adrenal cortex with IC50 value is 0.44uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 34 In Stock
100MG 50 In Stock
500MG 143 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Azilsartan Methyl Ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Azilsartan Methyl Ester is an angiotensin II receptor antagonist. Azilsartan Methyl Ester inhibits specific binding of [125I]AII (0.2 nM) to bovine adrenal cortex with IC50 value is 0.44uM.
  • Description
    Azilsartan methyl ester, a derivative of Azilsartan (HY-14914), is an angiotensin II receptor antagonist that plays an important role in hypertension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147403-52-9
  • Formula Weight
    470.48
  • Molecular Formula
    C26H22N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOc1nc2cccc(C(=O)OC)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Alison Handley, et al. Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study. Clin Exp Hypertens. 2016;38(2):180-8.
molnova catalog
related products
  • Terlakiren

    Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.

  • Trans-Tranilast

    Trans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.

  • Buloxibutid

    Buloxibutid (AT2 receptor agonist C21) is a novel and selective small molecule angiotensin II AT2 receptor agonist, exhibiting Ki values of 0.4 nM and 10 μM for AT2 and AT1 receptors, respectively.